234 related articles for article (PubMed ID: 29097503)
1. Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.
Capogrosso RF; Mantuano P; Uaesoontrachoon K; Cozzoli A; Giustino A; Dow T; Srinivassane S; Filipovic M; Bell C; Vandermeulen J; Massari AM; De Bellis M; Conte E; Pierno S; Camerino GM; Liantonio A; Nagaraju K; De Luca A
FASEB J; 2018 Feb; 32(2):1025-1043. PubMed ID: 29097503
[TBL] [Abstract][Full Text] [Related]
2. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle.
Lindsay A; Larson AA; Verma M; Ervasti JM; Lowe DA
J Appl Physiol (1985); 2019 Feb; 126(2):363-375. PubMed ID: 30571283
[TBL] [Abstract][Full Text] [Related]
3. Mechanical factors tune the sensitivity of mdx muscle to eccentric strength loss and its protection by antioxidant and calcium modulators.
Lindsay A; Baumann CW; Rebbeck RT; Yuen SL; Southern WM; Hodges JS; Cornea RL; Thomas DD; Ervasti JM; Lowe DA
Skelet Muscle; 2020 Feb; 10(1):3. PubMed ID: 32007101
[TBL] [Abstract][Full Text] [Related]
4. Rycal S48168 (ARM210) for
Todd JJ; Lawal TA; Chrismer IC; Kokkinis A; Grunseich C; Jain MS; Waite MR; Biancavilla V; Pocock S; Brooks K; Mendoza CJ; Norato G; Cheung K; Riekhof W; Varma P; Colina-Prisco C; Emile-Backer M; Meilleur KG; Marks AR; Webb Y; Marcantonio EE; Foley AR; Bönnemann CG; Mohassel P
EClinicalMedicine; 2024 Feb; 68():102433. PubMed ID: 38318125
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
6. A long-term treatment with taurine prevents cardiac dysfunction in mdx mice.
Mele A; Mantuano P; De Bellis M; Rana F; Sanarica F; Conte E; Morgese MG; Bove M; Rolland JF; Capogrosso RF; Pierno S; Camerino GM; Trabace L; De Luca A
Transl Res; 2019 Feb; 204():82-99. PubMed ID: 30347179
[TBL] [Abstract][Full Text] [Related]
7. Nanoscale remodeling of ryanodine receptor cluster size underlies cerebral microvascular dysfunction in Duchenne muscular dystrophy.
Pritchard HAT; Pires PW; Yamasaki E; Thakore P; Earley S
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):E9745-E9752. PubMed ID: 30181262
[TBL] [Abstract][Full Text] [Related]
8. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
9. Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient mdx mice.
Spurney CF; Sali A; Guerron AD; Iantorno M; Yu Q; Gordish-Dressman H; Rayavarapu S; van der Meulen J; Hoffman EP; Nagaraju K
J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):87-95. PubMed ID: 21304057
[TBL] [Abstract][Full Text] [Related]
10. TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice.
Call JA; Ervasti JM; Lowe DA
J Appl Physiol (1985); 2011 Jul; 111(1):200-5. PubMed ID: 21565990
[TBL] [Abstract][Full Text] [Related]
11. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
13. Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Kayali R; Ku JM; Khitrov G; Jung ME; Prikhodko O; Bertoni C
Hum Mol Genet; 2012 Sep; 21(18):4007-20. PubMed ID: 22692682
[TBL] [Abstract][Full Text] [Related]
14. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle.
Bellinger AM; Reiken S; Carlson C; Mongillo M; Liu X; Rothman L; Matecki S; Lacampagne A; Marks AR
Nat Med; 2009 Mar; 15(3):325-30. PubMed ID: 19198614
[TBL] [Abstract][Full Text] [Related]
15. Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathway.
Xu DQ; Zhao L; Li SJ; Huang XF; Li CJ; Sun LX; Li XH; Zhang LY; Jiang ZZ
Acta Pharmacol Sin; 2021 Jul; 42(7):1080-1089. PubMed ID: 32939036
[TBL] [Abstract][Full Text] [Related]
16. Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.
Spurney CF; Guerron AD; Yu Q; Sali A; van der Meulen JH; Hoffman EP; Nagaraju K
BMC Cardiovasc Disord; 2011 May; 11():20. PubMed ID: 21575230
[TBL] [Abstract][Full Text] [Related]
17. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
18. Nifedipine treatment reduces resting calcium concentration, oxidative and apoptotic gene expression, and improves muscle function in dystrophic mdx mice.
Altamirano F; Valladares D; Henríquez-Olguín C; Casas M; López JR; Allen PD; Jaimovich E
PLoS One; 2013; 8(12):e81222. PubMed ID: 24349043
[TBL] [Abstract][Full Text] [Related]
19. The proton pump inhibitor lansoprazole improves the skeletal phenotype in dystrophin deficient mdx mice.
Sali A; Many GM; Gordish-Dressman H; van der Meulen JH; Phadke A; Spurney CF; Cnaan A; Hoffman EP; Nagaraju K
PLoS One; 2013; 8(7):e66617. PubMed ID: 23843959
[TBL] [Abstract][Full Text] [Related]
20. Influence of hindlimb suspension on calcium-induced contraction characteristics in dystrophin-deficient animals.
Litvinova KS; Shenkman BS
J Gravit Physiol; 2007 Jul; 14(1):P91-2. PubMed ID: 18372714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
